EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Methylation‐based alcohol consumption scores as prognostic biomarkers in colorectal cancer: Insights from a population‐based cohort

Tanwei Yuan iD, Katrin E Tagscherer iD, Wilfried Roth, Melanie Bewerunge-Hudler, Alexander Brobeil, Matthias Kloor, Hendrik Bläker, Hermann Brenner, Michael Hoffmeister iD

International Journal of Cancer · 2025

DOI: 10.1002/ijc.70086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Tanwei Yuan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. Hauptthemen laut MEDLINE: DNA Methylation, Colorectal Neoplasms, Alcohol Drinking, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the German Research Council, the German Federal Ministry of Education and Research, the Interdisciplinary Research Program of the National Center for Tumor Diseases (NCT), Germany.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) remains a leading cause of cancer‐related mortality, with alcohol consumption implicated in its etiology. However, alcohol's prognostic impact on CRC survival is unclear, and self‐reported intake is limited by bias. This population‐based cohort study evaluated blood DNA methylation‐based alcohol scores as objective prognostic tools in 2,129 CRC patients from Germany's DACHS study (2003–2021; median follow‐up: 10 years). Participants were recruited from 22 hospitals in Southwest Germany, including non‐metastatic ( n = 1757) and metastatic ( n = 372) patients with complete methylation and alcohol data. All three assessed methylation scores (3‐CpG, 450‐CpG, 144‐CpG) correlated with self‐reported lifetime/recent alcohol intake (Spearman's r : 0.29–0.36; p < 0.0001), particularly recent consumption. In non‐metastatic patients, self‐reported alcohol consumption showed a J‐shaped mortality risk, with elevated risks in heavy drinkers and abstainers. A similar dose–response pattern was observed for the 3‐CpG methylation score, which showed consistent and robust associations with increased overall mortality (adjusted hazard ratio [aHR] per standard deviation increase: 1.18, 95% CI: 1.11–1.25), non‐CRC‐related mortality (1.22, 1.13–1.32), and CRC‐specific mortality (1.12, 1.00–1.25). The 450‐CpG score was associated with overall mortality (1.07, 1.00–1.15), non‐CRC‐related mortality (1.14, 1.05–1.23), and alcohol consumption‐related mortality (1.59, 1.17–2.16). These findings highlight the potential utility of DNA methylation‐based alcohol scores, especially the 3‐CpG and the 450‐CpG scores, as prognostic tools for CRC outcomes. Such biomarkers may provide a more objective measure of alcohol exposure and complement self‐reported data in risk stratification and clinical decision‐making, though further validation is warranted before clinical implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationColorectal NeoplasmsAlcohol DrinkingBiomarkers, TumorHumansFemaleMalePrognosisMiddle AgedAgedCohort StudiesGermanyCpG IslandsFollow-Up StudiesSelf Report

Stichwörter der Autor:innen

DNA methylationalcohol consumptioncolorectal cancerpopulation‐based cohortprognosis

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
  • Institute of Pathology, University Medical Center Mainz, Mainz, Germany.
  • Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Microarray Core Facility, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Institute of Pathology, University of Leipzig Medical Center, Leipzig, Germany.

ORCID-Profile: Tanwei Yuan, Katrin E Tagscherer, Michael Hoffmeister

Förderung

  • the German Research Council
  • the German Federal Ministry of Education and Research
  • the Interdisciplinary Research Program of the National Center for Tumor Diseases (NCT), Germany

Zitieren

APA

Yuan, T., Tagscherer, K. E., Roth, W., Bewerunge-Hudler, M., Brobeil, A., Kloor, M., Bläker, H., Brenner, H., & Hoffmeister, M. (2025). Methylation‐based alcohol consumption scores as prognostic biomarkers in colorectal cancer: Insights from a population‐based cohort. International Journal of Cancer. https://doi.org/10.1002/ijc.70086

Vancouver

Yuan T, Tagscherer KE, Roth W, Bewerunge-Hudler M, Brobeil A, Kloor M, et al. Methylation‐based alcohol consumption scores as prognostic biomarkers in colorectal cancer: Insights from a population‐based cohort. International Journal of Cancer. 2025. doi:10.1002/ijc.70086

BibTeX
@article{Yuan2025,
  author = {Yuan, Tanwei and Tagscherer, Katrin E and Roth, Wilfried and Bewerunge-Hudler, Melanie and Brobeil, Alexander and Kloor, Matthias and Bläker, Hendrik and Brenner, Hermann and Hoffmeister, Michael},
  title = {Methylation‐based alcohol consumption scores as prognostic biomarkers in colorectal cancer: Insights from a population‐based cohort},
  journal = {International Journal of Cancer},
  year = {2025},
  doi = {10.1002/ijc.70086}
}
Kostenlos starten →